PMGC Holdings, Inc. (ELAB)
1.62
-0.03
(-1.82%)
USD |
NASDAQ |
Nov 06, 10:20
PMGC Holdings Enterprise Value : -4.452M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | -4.452M |
| November 04, 2026 | -4.436M |
| November 03, 2026 | -4.435M |
| November 02, 2026 | -4.425M |
| October 30, 2026 | -4.394M |
| October 29, 2026 | -4.392M |
| October 28, 2026 | -4.396M |
| October 27, 2026 | -4.395M |
| October 26, 2026 | -4.394M |
| October 23, 2026 | -4.388M |
| October 22, 2026 | -4.390M |
| October 21, 2026 | -4.383M |
| October 20, 2026 | -4.381M |
| October 19, 2026 | -4.38M |
| October 16, 2026 | -4.384M |
| October 15, 2026 | -4.367M |
| October 14, 2026 | -4.371M |
| October 13, 2026 | -4.372M |
| October 12, 2026 | -4.366M |
| October 09, 2026 | -4.365M |
| October 08, 2026 | -4.362M |
| October 07, 2026 | -4.361M |
| October 06, 2026 | -4.353M |
| October 05, 2026 | -4.353M |
| October 02, 2026 | -4.347M |
| Date | Value |
|---|---|
| October 01, 2026 | -4.356M |
| September 30, 2026 | -4.336M |
| September 29, 2026 | -4.328M |
| September 28, 2026 | -4.26M |
| September 25, 2026 | -4.273M |
| September 24, 2026 | -4.276M |
| September 23, 2026 | -4.275M |
| September 22, 2026 | -4.292M |
| September 21, 2026 | -4.282M |
| September 18, 2026 | -4.26M |
| September 17, 2026 | -4.264M |
| September 16, 2026 | -4.261M |
| September 15, 2026 | -4.258M |
| September 14, 2026 | -4.270M |
| September 11, 2026 | -4.276M |
| September 10, 2026 | -4.271M |
| September 09, 2026 | -4.270M |
| September 08, 2026 | -4.256M |
| September 04, 2026 | -4.234M |
| September 03, 2026 | -4.232M |
| September 02, 2026 | -4.241M |
| September 01, 2026 | -4.245M |
| August 31, 2026 | -4.235M |
| August 28, 2026 | -4.227M |
| August 27, 2026 | -4.196M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zivo Bioscience, Inc. | 34.68M |
| Shonghoya Intl Group, Inc. | 33.64M |
| TFA Therapeutics, Inc. | -- |
| Arcadia Biosciences, Inc. | -3.814M |
| CCA Industries, Inc. | 3.500M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.959M |
| Revenue (Quarterly) | 1.307M |
| Total Expenses (Quarterly) | 4.266M |
| EPS Diluted (Quarterly) | -60.32 |
| Gross Profit Margin (Quarterly) | 8.00% |
| Profit Margin (Quarterly) | -226.5% |
| Earnings Yield | -1.12M% |
| Normalized Earnings Yield | -1.072M |